These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26047124)

  • 1. Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
    Moyen N; Thirion L; Emmerich P; Dzia-Lepfoundzou A; Richet H; Boehmann Y; Dimi Y; Gallian P; Gould EA; Günther S; de Lamballerie X
    PLoS Negl Trop Dis; 2015; 9(6):e0003833. PubMed ID: 26047124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus.
    Pourrut X; Souris M; Towner JS; Rollin PE; Nichol ST; Gonzalez JP; Leroy E
    BMC Infect Dis; 2009 Sep; 9():159. PubMed ID: 19785757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.
    Mulangu S; Borchert M; Paweska J; Tshomba A; Afounde A; Kulidri A; Swanepoel R; Muyembe-Tamfum JJ; Van der Stuyft P
    BMC Infect Dis; 2016 Jun; 16():263. PubMed ID: 27286990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.
    Nyakarahuka L; Schafer IJ; Balinandi S; Mulei S; Tumusiime A; Kyondo J; Knust B; Lutwama J; Rollin P; Nichol S; Shoemaker T
    BMC Infect Dis; 2020 Jul; 20(1):461. PubMed ID: 32611400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
    Bratcher A; Hoff NA; Doshi RH; Gadoth A; Halbrook M; Mukadi P; Musene K; Ilunga-Kebela B; Spencer D; Bramble MS; McIlwan D; Kelly JD; Mukadi D; Kingebeni PM; Ahuka S; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009566. PubMed ID: 34383755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evidence of Ebola virus infection in Indonesian orangutans.
    Nidom CA; Nakayama E; Nidom RV; Alamudi MY; Daulay S; Dharmayanti IN; Dachlan YP; Amin M; Igarashi M; Miyamoto H; Yoshida R; Takada A
    PLoS One; 2012; 7(7):e40740. PubMed ID: 22815803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
    Mulangu S; Alfonso VH; Hoff NA; Doshi RH; Mulembakani P; Kisalu NK; Okitolonda-Wemakoy E; Kebela BI; Marcus H; Shiloach J; Phue JN; Wright LL; Muyembe-Tamfum JJ; Sullivan NJ; Rimoin AW
    J Infect Dis; 2018 Jan; 217(4):529-537. PubMed ID: 29329455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Filoviridae: Marburg and Ebola viruses.
    Beer B; Kurth R; Bukreyev A
    Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
    Bausch DG; Borchert M; Grein T; Roth C; Swanepoel R; Libande ML; Talarmin A; Bertherat E; Muyembe-Tamfum JJ; Tugume B; Colebunders R; Kondé KM; Pirad P; Olinda LL; Rodier GR; Campbell P; Tomori O; Ksiazek TG; Rollin PE
    Emerg Infect Dis; 2003 Dec; 9(12):1531-7. PubMed ID: 14720391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic Prevalence of Ebola Virus in Equatorial Africa.
    Steffen I; Lu K; Yamamoto LK; Hoff NA; Mulembakani P; Wemakoy EO; Muyembe-Tamfum JJ; Ndembi N; Brennan CA; Hackett J; Stramer SL; Switzer WM; Saragosti S; Mbensa GO; Laperche S; Rimoin AW; Simmons G
    Emerg Infect Dis; 2019 May; 25(5):911-918. PubMed ID: 31002071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges.
    Grant-Klein RJ; Altamura LA; Badger CV; Bounds CE; Van Deusen NM; Kwilas SA; Vu HA; Warfield KL; Hooper JW; Hannaman D; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2015; 11(8):1991-2004. PubMed ID: 25996997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of vaccines for Marburg hemorrhagic fever.
    Bausch DG; Geisbert TW
    Expert Rev Vaccines; 2007 Feb; 6(1):57-74. PubMed ID: 17280479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
    Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
    J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.
    Nyakarahuka L; Kankya C; Krontveit R; Mayer B; Mwiine FN; Lutwama J; Skjerve E
    BMC Infect Dis; 2016 Nov; 16(1):708. PubMed ID: 27887599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous detection of Marburg virus and Ebola virus with TaqMan-based multiplex real-time PCR method.
    Yu Z; Wu H; Huang Q; Zhong Z
    J Clin Lab Anal; 2021 Jun; 35(6):e23786. PubMed ID: 33939238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.